Copyright © 2002 by the European Society of Cardiology.
Editorials
Homocysteine, smoking and vascular disease
Department of Cardiovascular Medicine, University of New South Wales, Prince of Wales Hospital, Sydney, Australia
References
- Carson N, Cusworth D, Dent C. Homocystinuria: a new inborn error of metabolism associated with mental deficiency. Archives of diseases in childhood. 1963;38:425–436
[Free Full Text] - Mudd S, Finkelstein J, Irreverre F. Homocystinuria: An enzymatic defect. Science. 1964;143:1443–1445
[Abstract/Free Full Text] - McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111–128[Web of Science][Medline]
- Mudd SH, Skovby F, Levy HL. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1985;37:1–31[Web of Science][Medline]
- Wilcken DE, Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis. 1997;20:295–300[CrossRef][Web of Science][Medline]
- Yap S, Boers GH, Wilcken B. Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study. Arterioscler Thromb Vasc Biol. 2001;21:2080–2085
[Abstract/Free Full Text] - Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest. 1976;57:1079–1082[Web of Science][Medline]
- Wang XL, Tam C, McCredie RM. Determinants of severity of coronary artery disease in Australian men and women. Circulation. 1994;89:1974–1981
[Abstract/Free Full Text] - Refsum H, Ueland PM, Nygard O. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49:31–62[CrossRef][Web of Science][Medline]
- Seshadri S, Beiser A, Selhub J. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med. 2002;346:476–483
[Abstract/Free Full Text] - Nygard O, Vollset SE, Refsum H. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA. 1995;274:1526–1533
[Abstract/Free Full Text] - O’Callaghan P, Meleady R, Fitzgerald T. Smoking and plasma homocysteine. Eur Heart J. 2002;23:1580–1586
[Abstract/Free Full Text] - Doshi SN, McDowell IF, Moat SJ. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide? Arterioscler Thromb Vasc Biol. 2001;21:1196–1202
[Abstract/Free Full Text] - Verhaar MC, Stroes E, Rabelink TJ. Folates and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2002;22:6–13
[Abstract/Free Full Text] - Usui M, Matsuoka H, Miyazaki H. Endothelial dysfunction by acute hyperhomocyst(e)inaemia: restoration by folic acid. Clin Sci (Lond). 1999;96:235–239[Medline]
- Yamamoto M, Hara H, Adachi T. Effects of homocysteine on the binding of extracellular-superoxide dismutase to the endothelial cell surface. FEBS Lett. 2000;486:159–162[CrossRef][Web of Science][Medline]
- Morrow JD, Frei B, Longmire AW. Increase in circulating products of lipid peroxidation (F2–isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. 1995;332:1198–1203
[Abstract/Free Full Text] - Clarke R, Collins R. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease. J Cardiovasc Risk. 1998;5:249–255[Medline]
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||